New aspirin guidance influenced by Minnesota research
HealthPartners modeling helps show certain age groups benefit from daily aspirin more than others.
www.startribune.com
“The task force urges people 40-59 with 10% risk of heart disease in a decade to talk with their doctors about aspirin, whereas it previously recommended the pills for people in their 50s but offered no guidance to younger adults. The task force in 2016 told people in their 60s to talk with doctors but now discourages anyone 60 or older from starting daily aspirin therapy to lower cardiac risk.”
